TELA Bio, Inc. (TELA) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $80.28M | +15.8% |
| 2024 | $69.30M | +18.6% |
| 2023 | $58.45M | +41.1% |
| 2022 | $41.42M | +40.6% |
| 2021 | $29.46M | +61.8% |
| 2020 | $18.21M | +17.9% |
| 2019 | $15.45M | +86.7% |
| 2018 | $8.27M | +94.9% |
| 2017 | $4.25M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $80.28M | +15.8% |
| 2024 | $69.30M | +18.6% |
| 2023 | $58.45M | +41.1% |
| 2022 | $41.42M | +40.6% |
| 2021 | $29.46M | +61.8% |
| 2020 | $18.21M | +17.9% |
| 2019 | $15.45M | +86.7% |
| 2018 | $8.27M | +94.9% |
| 2017 | $4.25M | — |